The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells
Abstract
Patients with solid tumors are increasingly being treated by autologous bone marrow transplantation (BMT). Although response rates appear to be increased, disease recurrence is the commonest cause of treatment failure. Whether relapse is entirely due to residual disease in the patient or arises also from infiltrating malignant cells contained in the autologous marrow transplant has not been resolved. If the latter explanation is correct, then purging would be required as part of the transplantation procedure. We used retrovirally mediated transfer of the neomycin-resistance gene to mark BM harvested from eight patients with neuroblastoma in clinical remission. The marked marrow cells were subsequently reinfused as part of an autologous BMT. At relapse, we sought the marker gene in malignant cell populations. Three patients have relapsed, and in each the marker gene was detected by phenotypic and genetic analyses of resurgent malignant cells at medullary and extramedullary sites. Analysis of neuroblast DNA for discrete marker gene integration sites suggested that at least 200 malignant cells, each capable of tumor formation, were introduced with the autologous marrow transplant and contributed to relapse. Thus, autologous BMTs administered to patients with this solid tumor may contain a multiplicity of malignant cells that subsequently contribute to relapse. The marker-gene technique we describe should permit evaluation of the mechanisms of relapse and the efficacy of purging in patients receiving autologous marrow transplantation for other solid tumors that infiltrate the marrow.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic applications of an inverse polymerase chain reaction.
Ochman, H., Gerber, A. S., & Hartl, D. L. (1988) · Genetics · doi:10.1093/genetics/120.3.621 · Cited by 1,859
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
Brenner, M. K., Rill, D. R., Krance, R. A., Ihle, J. N., Moen, R. C., Mirro, J., & Anderson, W. F. (1993) · The Lancet · doi:10.1016/0140-6736(93)92560-g · Cited by 893
Self-citationTriglia, T., Peterson, M. G., & Kemp, D. J. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.16.8186 · Cited by 809
Gribben, J. G., Freedman, A. S., Neuberg, D., Roy, D. C., Blake, K. W., Woo, S. D., Grossbard, M. L., Rabinowe, S. N., Coral, F., Freeman, G. J., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111283252201 · Cited by 668
Yeager, A. M., Kaizer, H., Santos, G. W., Saral, R., Colvin, O. M., Stuart, R. K., Braine, H. G., Burke, P. J., Ambinder, R. F., Burns, W. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607173150301 · Cited by 431
Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region
Bender, M. A., Palmer, T. D., Gelinas, R. E., & Miller, A. D. (1987) · Journal of Virology · doi:10.1128/jvi.61.5.1639-1646.1987 · Cited by 410
Brenner, M. K., Santana, V. M., Rill, D. R., Holladay, M. S., Heslop, H. E., Buschle, M., Krance, R. A., Moen, R. C., Anderson, W. F., & Ihle, J. N. (1993) · The Lancet · doi:10.1016/0140-6736(93)92122-a · Cited by 401
Self-citationGraham‐Pole, J., Casper, J. T., Elfenbein, G. J., Gee, A. P., Gross, S., Janssen, W. E., KOCH, P. A., Marcus, R., Pick, T. E., & Shuster, J. J. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.1.152 · Cited by 118
Rill, D. R., Moen, R., Buschle, M., Bartholomew, C., Foreman, N., Mirro, J., Krance, R. A., Ihle, J. N., & Brenner, M. K. (1992) · Blood · doi:10.1182/blood.v79.10.2694.2694 · Cited by 89
Self-citation
Cited by
Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor Antagonist
Dinarello, C. A. (1998) · International Reviews of Immunology · doi:10.3109/08830189809043005 · Cited by 761
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
Lyman, S. D., & Jacobsen, S. E. W. (1998) · Blood · doi:10.1182/blood.v91.4.1101 · Cited by 696
Kohn, D. B., Weinberg, K. I., Nolta, J. A., Heiss, L. N., Lenarsky, C., Crooks, G. M., Hanley, M. E., Annett, G., Brooks, J. S., El-Khoureiy, A., et al. (1995) · Nature Medicine · doi:10.1038/nm1095-1017 · Cited by 594
Self-citationDunbar, C., Cottler-Fox, M., O'Shaughnessy, J., Doren, S., Carter, C., Berenson, R., Brown, S., Moen, R., Greenblatt, J., & Stewart, F. (1995) · Blood · doi:10.1182/blood.v85.11.3048.bloodjournal85113048 · Cited by 449
Self-citationA functional comparison of CD34 + CD38- cells in cord blood and bone marrow
Hao, Q., Shah, A., Thiemann, F., Smogorzewska, E., & Crooks, G. (1995) · Blood · doi:10.1182/blood.v86.10.3745.bloodjournal86103745 · Cited by 434
Metadata
- Authors
- Rill, D., Santana, V., Roberts, W., Nilson, T., Bowman, L., Krance, R., Heslop, H., Moen, R., Ihle, J., & Brenner, M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1994-07-15
- Volume
- 84
- Issue
- 2
- Pages
- 380-383
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2242711566
- Cited by
- 406
- References
- 9
- FWCI
- 22.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. https://app.cochat.ai/papers/10.1182/blood.v84.2.380.380
- The paper
- Rill, D., Santana, V., Roberts, W., Nilson, T., Bowman, L., Krance, R., Heslop, H., Moen, R., Ihle, J., & Brenner, M. (1994). Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood. https://doi.org/10.1182/blood.v84.2.380.380
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.